Clients wrestling with complex or bet-the-business intellectual property and commercial litigation turn to George Pappas. Ranked in the top tier of lawyers for Intellectual Property by Chambers USA, clients have described Mr. Pappas as, "a class apart", "has tremendous presence in the courtroom and understands the legal issues very well. He is both thorough and unrelenting.” His peers have commented that, “He is a fantastic lead trial lawyer and, though very tough to compete against, is a true gentleman."
Mr. Pappas has served as lead trial counsel in hundreds of cases, having appeared in federal and state courts throughout the United States and internationally. He has successfully represented clients across a broad range of industries including pharmaceutical, medical device, biotechnology, computer and electronics, software, telecommunications, and the financial services industry.
Mr. Pappas is a Fellow of the American College of Trial Lawyers and Chairman of its Complex Litigation Committee (2009-2011). He is also Chairman of the Editorial Committee and one of the co-authors of the book, Anatomy of a Patent Case (2009; 2012 2nd ed.), prepared by the Complex Litigation Committee of the American College of Trial Lawyers and published in conjunction with the Federal Judicial Center. Notably, the book has been distributed to all judges of the federal judicial branch. He also is on the Practitioner and Academic Advisory Board of the Patent Case Management Judicial Guide (2009).
At the invitation of the Federal Judicial Center (FJC) beginning in 1996, Mr. Pappas has presented programs on patent law issues at 37 FJC National Workshops for federal district and magistrate judges. He also serves as a member of the District of New Jersey Local Patent Rules Committee
Hatch-Waxman & Pharmaceutical
- Representation of AstraZeneca in Hatch-Waxman patent litigation against Barr and Mylan concerning Entocort® EC, used for the treatment of Crohn’s disease. AstraZeneca LP v. Mylan Pharmaceuticals, Inc (D. Del.).
- Representation of Bristol-Myers Squibb in patent litigation in the District of New Jersey against Dr. Reddy’s Laboratories relating to IXEMPRA® Kit, an intravenous infusion treatment for metastatic or locally advanced breast cancer after failure of at least an anthracycline and a taxane. Bristol-Myers Squibb Company v. Dr. Reddy’s Laboratories Ltd., et al. (D.N.J.).
- Representation of Merck before the International Trade Commission, as well as parallel district court litigation. Due to our efforts, the Complainant/Plaintiff dismissed its complaint in the ITC, as well as in the Eastern District of Virginia. In re Certain Vaginal Ring Birth Control Devices (USITC) and Femina Pharma Inc. v. Merck & Co., Inc., et al. (E.D. Va.).
- Representation of Auxilium Pharmaceuticals in a Hatch-Waxman case involving transdermal testosterone gel for treatment of male hypogonadism . Auxilium Pharmaceuticals, Inc. and Cpex Pharmaceuticals, Inc. v. Upsher-Smith Laboratories, Inc. (D. Del.).
- Representation of GlaxoSmithKline in patent litigation brought by Classen Immunotherapies involving immunization methods and schedules. Classen Immunotherapies, Inc. v. Biogen IDEC, et al. (D. Md.).
- Representation of Ortho-McNeil in:
- the District of New Jersey in an ANDA case brought against Lupin involving Ortho Tri-Cyclen® Lo. Following a bench trial, the judge ruled in favor of our client, declaring the patent valid, blocking Lupin’s effort to market a generic competitor. Janssen Pharms Inc. v. Lupin Pharms , Inc. et al. (D.N.J.);
- the District of New Jersey in an ANDA case brought against Barr relating to a patent covering Ortho Tri-Cyclen ® Lo, an oral contraceptive. Trial was adjourned when settlement discussions began the first day of trial. When settlement did not materialize, we moved for a preliminary injunction and a recall of the infringing product, which had already been sent to distributors and pharmacies, and it was granted. We subsequently obtained a highly favorable settlement for our client. Ortho McNeil Pharmaceutical, Inc. v. Barr Laboratories, Inc. (D.N.J. 2009); and
- the Northern District of West Virginia and the Court of Appeals for the Federal Circuit in an ANDA case brought by Mylan Laboratories relating to a patent covering Levaquin®, an antibiotic. Ortho-McNeil prevailed in the district court, and the decision was affirmed per curium by the Federal Circuit. Ortho-McNeil Pharmaceuticals, Inc. v. Mylan Laboratories, Inc. (N.D.W. Va.).
- Representation of Sanofi in Hatch-Waxman litigations against Accord Healthcare, Sandoz, and Sun Pharmaceuticals concerning Sanofi's Taxotere® cancer treatment. sanofi-aventis v. Accord Healthcare, sanofi-aventis v. Sandoz, sanofi-aventis v. Sun Pharmaceuticals (D. Del.).
- Representation of Shire in the District of New Jersey and the Southern District of Florida in an ANDA case brought against Andrx and Watson concerning Shire’s ADDERALL XR® product for the treatment of ADHD. Shire Laboratories Inc v. Andrx Pharmaceutical, LLC et al (D.N.J.) and Shire Laboratories Inc v. Andrx Pharmaceutical, LLC et al (S.D. Fla.).
Honors and Rankings
- Fellow, American College of Trial Lawyers
- Chairman, Complex Litigation Committee of the American College of Trial Lawyers
- Listed as one of The Best Lawyers in America in Bet-the-Company Litigation, Commercial Litigation, and Intellectual Property Law (2006-2014)
- Listed in Chambers USA 2006-2013 and Chambers Global 2007-2013 as a leading attorney in the area of Intellectual Property
- The International Who's Who of Life Sciences Lawyers (2012)
- IAM Patent 1000 - The World’s Leading Patent Practitioners (2012)
- Who's Who Legal, Patents (2012-2013)
- Legal 500 US, Intellectual Property - Patent Litigation (2012-2013) and Litigation - Supreme Court & Appellate (2013)
- Top 100 Washington D.C. Area Super Lawyers (2013)
- Washington DC Super Lawyers, Intellectual Property Litigation (2007-2013)
- LMG Life Sciences Awards, shortlisted for Hatch-Waxman (Branded) Litigator of the Year (2013)
- LMG Life Sciences, "Life Science Star" (2013)
- Benchmark Litigation, National Star (2013-2014)
- Washingtonian, Intellectual Property "Top Lawyer" (2013)
- Named "The Top Business Litigator in DC" by Legal Times (2007)
Memberships and Affiliations
- The American Law Institute, Member (2002-Present)
- Consultative Group, Intellectual Property: Principles Governing Jurisdiction, Choice of Law, and Judgments in Transnational Disputes for The American Law Institute, Member
- Appointed by Chief Judge Garrett E. Brown, Jr. to serve as a Member of the District of New Jersey Local Patent Rules Committee
- Appointed by Chief Justice Rehnquist of the U.S. Supreme Court to serve as a Member of the District Judge Education Advisory Committee for the Federal Judicial Center (2001, 2004-2007)
- U.S. District Court of Delaware Judges’ Intellectual Property Advisory Committee, 1998, 2001, 2003-Present (invited by active Federal Judges of the Court), Member
- U.S. District Court of Delaware Electronic Discovery Committee, Member (2003-2006)
- ALI-ABA Advisory Group on Intellectual Property, Member (2004-Present)
- Maryland Statewide Business/Technology Case Management Advisory Committee, Member (2004-Present)
- Chairman, Governor’s Commission on Development of Advanced Technology Business (“Pappas Commission”) (2002 - 2004)
- Board of Visitors of the University of Maryland School of Law, Member (2000-Present)
- University of Maryland School of Law IP Program Advisory Board, Member, (2002-Present)
Publications and Speeches
Mr. Pappas is Editor and Co-Author of the book, Anatomy of a Patent Case (2009; 2012 2nd ed.), which is prepared by the Complex Litigation Committee of the American College of Trial Lawyers. He also is on the Practitioner and Academic Advisory Board of the Patent Case Management Judicial Guide (2009).
- "Obviousness & the Role of Secondary Considerations in Deciding Obviousness," International Judges Conference on Intellectual Property Law (5/23/2011)
- "Patentable Subject Matter Under U.S. Patent Law," 24th Annual IPSANZ Conference (September 2010)
- "Patent Local Rules and Pre-Trial Orders Roundtable: Philosophy, Context, Logic and Departures” and “Dealing with Complex Technology: Tutorials and Educating the Court about Technology," Moderator at the Berkeley Center for Law & Technology, Federal Judicial Center Advanced Patent Program (September 2010)